BSECompany Update▲ PositiveExpansion31 Jul 2026
Bajaj Finserv Ltd
The Board has granted approval for pursuing re-insurance business through a subsidiary of the Company to be incorporated, subject to approval of IRDAI and other authorities, as may be necessary.
Bajaj Finserv Ltd's board has approved pursuing re-insurance business through a subsidiary, subject to IRDAI and other authorities' approval.
NSEPress Release▲ PositiveOrder Win31 Jul 2026
Vikran Engineering Limited
Press Release
Vikran Engineering Limited has secured a ₹120.69 Crore order from Power Grid Corporation of India Limited (POWERGRID) for the 400 kV GIS Substation Extension Package SS-147.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026
Oriental Aromatics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Oriental Aromatics Limited has informed the Exchange about Earnings Call Presentation. The company has disclosed its Q1-FY27 consolidated financial performance, with sales volumes increasing by 22% YoY and EBITDA margin improving to 7.62%. The company has also highlighted its operational highlights, including production volumes growing by 18% YoY and a favourable product mix.
BSEBoard Meeting▲ PositiveResults31 Jul 2026
Bajaj Finserv Ltd
The Board Meeting commenced at 10:45 a.m. and concluded at 11.50 a.m.
Bajaj Finserv Ltd's board meeting outcome for the quarter ended 30 June 2026 includes approval of unaudited standalone and consolidated financial results, issue of equity shares to Bajaj Finserv ESOP Trust, and approval for pursuing re-insurance business.
NSEPress Release▲ PositiveExpansion31 Jul 2026
TVS Srichakra Limited
Press Release
TVS Srichakra Limited has opened three new exclusive retail stores in Mehsana, Gujarat and Noida & Bareilly, Uttar Pradesh, taking the total number of stores to 19.
NSEPress Release▲ PositiveOrder Win31 Jul 2026
Fischer Medical Ventures Limited
Press Release
Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has entered into a partnership with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.
BSECompany Update▲ PositiveExpansion31 Jul 2026
Ishan Dyes and Chemicals Ltd
We are submitting herewith Disclosure under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regualtions, 2015 - Commencement of Work for Four Additonal Sulphur- Based ....
Ishan Dyes and Chemicals Ltd has commenced activities for the production of four new high-value sulphur-based products at its Sulphuric Acid Unit, expected to be commercially launched within the next three months.
BSECompany Update▲ PositiveOrder Win31 Jul 2026
Fischer Medical Ventures Ltd
Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for Installation of Inter-Op MRI Suite.
Fischer Medical Ventures Ltd's wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has partnered with Parul Sevashram Hospital to install its revolutionary DRIS–iMRI Medharanya Suite, an AI-enabled next-generation portable intraoperative MRI system.
BSECompany Update▲ PositiveProduct Launch31 Jul 2026
Mahan Industries Ltd
As per attachment
Mahan Industries Ltd has launched a new digital lending platform called 'Credit Mines' which enables customers to avail personal loans and other credit products in a fully digital, paperless manner.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026
Share India Securities Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Share India Securities Limited has announced its Q1 FY 2027 earnings, with standalone revenue increasing by 28% YoY to Rs. 349 crores and profit after tax growing by 32% to Rs. 90.85 crore. The company's consolidated revenue from operation increased by 31% YoY to Rs. 448 crores, while profit after tax rose by 48% to Rs. 124.41 crore.
NSEGeneral Updates▲ PositiveExpansion31 Jul 2026
Ishan Dyes and Chemicals Limited
General Updates
Ishan Dyes and Chemicals Limited has commenced work on producing four new high-value sulphur-based products at its Sulphuric Acid Unit, expected to be commercially launched within three months, enhancing product diversification, market presence, and revenue opportunities.
NSECopy of Newspaper Publication▲ PositiveResults31 Jul 2026
Mahindra & Mahindra Limited
Copy of Newspaper Publication
Mahindra & Mahindra Limited has published its unaudited consolidated and standalone financial results for the quarter ended 30th June 2026, showing a profit of Rs. 5,454.54 crores and Rs. 3,684.97 crores respectively, with a total income from operations of Rs. 58,187.57 crores and Rs. 41,958.76 crores respectively.
BSECompany Update▲ PositiveResults31 Jul 2026
Share India Securities Ltd
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached herewith the Transcript of Conference Call with Analysts/Investors held on July 27, 2026.
Share India Securities Ltd has announced its Q1 FY 2027 earnings, with standalone revenue increasing by 28% YoY to Rs. 349 crores and profit after tax growing by 32% to Rs. 90.85 crore. Consolidated revenue increased by 31% YoY to Rs. 448 crores, with consolidated PAT rising by 48% to Rs. 124.41 crore.
BSECompany Update▲ PositiveResults31 Jul 2026
Mahindra & Mahindra Ltd
Please refer enclosed file
Mahindra & Mahindra Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended 30th June 2026, showing a total income from operations of Rs. 58,187.57 crore and a profit for the period of Rs. 5,454.54 crore.
BSECompany Update▲ PositiveOrder Win31 Jul 2026
Lupin Ltd
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection.
Lupin Ltd has announced the US FDA approval and launch of Sugammadex Injection in the US market.
NSEPress Release▲ PositiveOrder Win31 Jul 2026
Lupin Limited
Press Release
Lupin Limited has announced the U.S. FDA approval and launch of Sugammadex Injection, a bioequivalent to Bridion Injection of Merck, for the reversal of neuromuscular blockade in adults and pediatric patients undergoing surgery.
BSECompany Update▲ PositiveResults31 Jul 2026
Spandana Sphoorty Financial Ltd
Transcript of earnings call for the quarter ended June 30, 2026.
Spandana Sphoorty Financial Ltd's Q1 FY27 earnings conference call transcript reveals a good quarter with AUM growth of 11% to INR4,887 crores, new member addition of 61%, and annualized credit cost at 2.1%. The company collected INR51 crores in the 90-plus pool and garnered INR545 crores in sanctions under the credit guarantee scheme. PAT was INR12 crores, up from INR5 crores in the March '26 quarter. The company is focusing on growth in Tamil Nadu and Maharashtra, and is piloting an individual loan product in 8 branches in Madhya Pradesh.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults31 Jul 2026
Spandana Sphoorty Financial Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Spandana Sphoorty Financial Limited held an analysts/institutional investor meet/conference call to discuss Q1 FY27 earnings. Key highlights include an 11% QoQ growth in AUM to INR4,887 crores, new member addition of 61% and 1.38 lakh members, and a net credit cost of 2.1%. The company aims to double its share in Maharashtra and pilot an individual loan product in Madhya Pradesh.
BSECompany Update▲ PositiveResults31 Jul 2026
Anlon Healthcare Ltd
We have attached press release for Financial Results for the Quarter Ended June 30, 2026.
Kindly take the same on your record.
Thank you.
Anlon Healthcare Limited has announced its unaudited Financial Results for Q1FY27, reporting a 163.02% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150.14% growth in EBITDA to ₹15.65 Crore, and 133.13% growth in Profit After Tax to ₹8.28 Crore. The company has strengthened its integrated pharmaceutical platform through strategic acquisitions, expanded its product portfolio, and improved operational synergies.
NSEPress Release▲ PositiveResults31 Jul 2026
Anlon Healthcare Limited
Press Release
Anlon Healthcare Limited has reported a 163% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150% growth in EBITDA to ₹15.65 Crore, and 133% growth in Profit After Tax to ₹8.28 Crore for Q1FY27.